December, 2024

As of Q3 2024, the median transaction value in healthcare was $56 million. As of Q3 2024, strategic buyers accounted for 93% of transactions.

Select recent notable publicly announced M&A transactions:

–Cardinal Health announced its acquisition of Integrated Oncology Network for $1.1 billion in September 2024.

–Crown Laboratories announced its acquisition of Revance Therapeutics for $1.2 billion in August 2024.

–Otsuka America closed its acquisition of Jnana Therapeutics for $1.3 billion in August 2024.

–Edwards Lifesciences Corporation announced its acquisition of JenaValve Technology for $945 million in July 2024.

–Illumina closed its acquisition of Fluent BioSciences for $85 million in July 2024.

    Download Report